University of Pennsylvania
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Pennsylvania sits in the top decile of US sponsors by registered trial count (#15 of 15,751 sponsors by registered trial count).
University of Pennsylvania: 1,423 sponsored US clinical trials, 199 recruiting.
University of Pennsylvania sponsors 1,423 registered US clinical trials on ClinicalTrials.gov, 199 of them currently recruiting, and 982 completed. 130 of these trials are in Phase 3-4 (later-stage) and 339 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 17 trials.
Top-decile sponsor footprint
University of Pennsylvania ranks in the top decile of sponsors by registered trial count (#15 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
1,423 total, page 18 of 29
Diet and Stool Metabolites in Fecal Incontinence
NCT02485522
Intuition vs. Deliberation in Medical Decision Making
NCT02487810
The ANCA Vasculitis Questionnaire (AAV-PRO©)
NCT02507024
Non-invasive Measurement of Cerebral Dynamic Autoregulation
NCT02442856
Way to Cure HCV Adherence
NCT02472925
Maternal Gut Microbiome (MGM) Study of Diet, the Gut Microbiome and Preterm Birth
NCT02560246
Intraoperative Imaging of Pulmonary Nodules by OTL38
NCT02602119
SmarToyGym: Smart Detection of Atypical Toy-oriented Actions in At-risk Infants
NCT02813889
Pilot Study of Autologous T-cells in Patients With Metastatic Pancreatic Cancer
NCT02465983
Topiramate's Effects on Heavy Drinking
NCT02074904
Fresh Start Experiment
NCT02411032
Expulsion of Immediate Postplacental Copper Intrauterine Devices at Six Months: A Prospective Cohort Study
NCT02706340
Dress for Success: Can Just Dressing for the Gym Help Going to the Gym?
NCT02411045
A Phase I Study of T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728mR in HIV-Infected Patients
NCT02388594
Web-based Intervention to Prevent Risky Driving
NCT02319317
Lipidomics Screening of Celecoxib in ex Vivo Human Whole Blood Assay - Part B
NCT02413203
The Study of Cardiovascular Outcomes in Women With Preeclampsia Using Echocardiography: The SCOPE Study
NCT02357667
Attention to Incentives
NCT02411058
The Effect of Prefrontal Cortex Stimulation on Antisocial and Aggressive Behavior
NCT02427672
CART-meso Long-term Follow-up
NCT02388828
Serial [18F]Thymidine (FLT)PET/CT as a Biomarker of Response in Pemetrexed Therapy for Non-Small Cell Lung Cancer
NCT02274038
Digital vs. Printed Photographs: Impact on Skin Self-Examinations
NCT02520622
GlowCaps Adherence Randomized Control Trial
NCT01756001
Mobile App for Mood in Pregnancy (Ginger iO)
NCT02761720
Effects of Use of a Connected Pillbox On Medication Adherence
NCT02593032
Process Versus Outcomes Incentives for Lipid Management
NCT02246959
Men Together Making a Difference: Health Promotion for Black Men
NCT02572414
Randomized Clinical Trial to Reduce Harm From Tobacco
NCT02328794
Mechanistic Study of Subclinical Hypothyroidism In the Elderly
NCT02399475
Pharmacokinetics, Pharmacodynamics, and Impact of Inorganic Nitrate on Exercise in HFpEF
NCT02256345
Creating Exercise Habits Through Incentives for Routines
NCT02346799
Lifestyle Modification and Lorcaserin for Weight Loss Maintenance
NCT02388568
CellulaR Injury and Preterm Birth
NCT02441335
A Randomized, Double-blind Placebo-Controlled Pharmacogenetic Study of Topiramate in European-American Heavy Drinkers
NCT02371889
Short-course Methenamine Hippurate for Prevention of Post-operative UTI
NCT02358993
Psoriasis Microbiome and Phototherapy
NCT02552316
Yoga Intervention for Substance Use and ART Adherence in Community Reentry
NCT02492893
EndoFLIP Use in Upper GI Tract Stenosis
NCT02354716
Autologous T Cells Redirected to EGFRVIII-With a Chimeric Antigen Receptor in Patients With EGFRVIII+ Glioblastoma
NCT02209376
Effect of Reminders on Adherence
NCT02411006
Assessment of Prospective CYP2C19 Genotype Guided Dosing of Anti-Platelet Therapy in Percutaneous Coronary Intervention
NCT02508116
Impact of Active Choice on Advance Directive Completion Rates
NCT02289105
Minimally Invasive Imagery With Indocyanine Green
NCT02621268
Safety and Cardiovascular Efficacy of Spironolactone in Dialysis-Dependent ESRD Trial
NCT02285920
Tau Imaging in Young Onset Dementia
NCT02289118
Dry Eye Assessment and Management Study
NCT02128763
Randomized Study of Daytime vs. Delayed Eating: Effect on Weight and Metabolism
NCT04414644
Effects of Implicit Messaging by Cigarette Pack Color on Smoking Behaviors
NCT02301351
Multicomponent Yoga Intervention for Major Depressive Disorder
NCT02616549
CD19 Redirected Autologous T Cells for Hodgkin Lymphoma
NCT02277522
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 182 |
| Phase 2 | 157 |
| Phase 3 | 43 |
| Phase 4 | 87 |
Therapeutic Areas
What is open in the University of Pennsylvania pipeline
199 recruiting of 1,423 indexed (14% open); 982 completed (69%).
Phase mix: 130 late (III/IV) vs 339 early (I/II) (early-phase heavy).
Top condition: Obesity (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.